Ralf Herold MD PhD is head of EMA’s Regulatory Science and Academia Workstream, in the Regulatory Science and Innovation Taskforce, coordinating engagement with the academic sector, not-for-profit organisations and institutions, previously working on cancer and paediatric medicines, horizon scanning and foresight. From 2017 to 2018, he was the Pediatric development leader at Bayer AG Regulatory affairs and an ICH E11A expert group member. At Charité – Universitätsmedizin Berlin, he obtained an experimental research PhD, board certified in paediatric and adolescent medicine, trained in paediatric oncology and haematology, and managed a national research network.